Towa Pharmaceutical Co., Ltd. (4553.T)
JPY 2637.0
(0.65%)
JPY 2637.0
(0.65%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 63.73 Billion JPY | -5.15% |
| 2022 | 67.19 Billion JPY | 31.81% |
| 2021 | 50.98 Billion JPY | 11.98% |
| 2020 | 45.52 Billion JPY | 31.95% |
| 2019 | 34.5 Billion JPY | 6.39% |
| 2018 | 32.43 Billion JPY | 3.26% |
| 2017 | 31.4 Billion JPY | -2.39% |
| 2016 | 32.17 Billion JPY | 4.74% |
| 2015 | 30.71 Billion JPY | 18.71% |
| 2014 | 25.87 Billion JPY | 14.89% |
| 2013 | 22.52 Billion JPY | 12.51% |
| 2012 | 20.01 Billion JPY | 13.58% |
| 2011 | 17.62 Billion JPY | 16.39% |
| 2010 | 15.14 Billion JPY | 21.09% |
| 2009 | 12.5 Billion JPY | 11.52% |
| 2008 | 11.21 Billion JPY | 15.71% |
| 2007 | 9.69 Billion JPY | 5.0% |
| 2006 | 9.22 Billion JPY | 7.82% |
| 2005 | 8.56 Billion JPY | 1.87% |
| 2004 | 8.4 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 17.67 Billion JPY | 6.89% |
| 2023 Q1 | 15.91 Billion JPY | -25.99% |
| 2023 FY | 63.73 Billion JPY | -5.15% |
| 2023 Q4 | 16.53 Billion JPY | 3.55% |
| 2023 Q3 | 15.96 Billion JPY | 4.18% |
| 2023 Q2 | 15.32 Billion JPY | -3.69% |
| 2022 FY | 67.19 Billion JPY | 31.81% |
| 2022 Q4 | 21.5 Billion JPY | 36.55% |
| 2022 Q2 | 15.22 Billion JPY | 3.41% |
| 2022 Q1 | 14.72 Billion JPY | 3.65% |
| 2022 Q3 | 15.74 Billion JPY | 3.4% |
| 2021 Q4 | 14.2 Billion JPY | 21.37% |
| 2021 Q2 | 12.9 Billion JPY | 6.03% |
| 2021 Q3 | 11.7 Billion JPY | -9.26% |
| 2021 Q1 | 12.16 Billion JPY | -0.5% |
| 2021 FY | 50.98 Billion JPY | 11.98% |
| 2020 Q2 | 11.21 Billion JPY | -0.94% |
| 2020 Q1 | 11.32 Billion JPY | 18.96% |
| 2020 FY | 45.52 Billion JPY | 31.95% |
| 2020 Q4 | 12.22 Billion JPY | 13.68% |
| 2020 Q3 | 10.75 Billion JPY | -4.13% |
| 2019 Q1 | 8.09 Billion JPY | -4.02% |
| 2019 Q3 | 8.07 Billion JPY | -8.46% |
| 2019 Q2 | 8.81 Billion JPY | 8.88% |
| 2019 FY | 34.5 Billion JPY | 6.39% |
| 2019 Q4 | 9.52 Billion JPY | 17.97% |
| 2018 Q1 | 8.09 Billion JPY | 4.15% |
| 2018 Q2 | 7.96 Billion JPY | -1.61% |
| 2018 FY | 32.43 Billion JPY | 3.26% |
| 2018 Q4 | 8.43 Billion JPY | 6.42% |
| 2018 Q3 | 7.92 Billion JPY | -0.53% |
| 2017 Q1 | 7.58 Billion JPY | -7.41% |
| 2017 Q4 | 7.77 Billion JPY | -0.18% |
| 2017 FY | 31.4 Billion JPY | -2.39% |
| 2017 Q3 | 7.79 Billion JPY | -5.62% |
| 2017 Q2 | 8.25 Billion JPY | 8.79% |
| 2016 Q3 | 7.61 Billion JPY | -11.68% |
| 2016 Q2 | 8.62 Billion JPY | 11.52% |
| 2016 FY | 32.17 Billion JPY | 4.74% |
| 2016 Q1 | 7.73 Billion JPY | -10.3% |
| 2016 Q4 | 8.19 Billion JPY | 7.55% |
| 2015 Q3 | 7.7 Billion JPY | 1.64% |
| 2015 Q1 | 6.8 Billion JPY | -5.59% |
| 2015 FY | 30.71 Billion JPY | 18.71% |
| 2015 Q4 | 8.62 Billion JPY | 11.9% |
| 2015 Q2 | 7.58 Billion JPY | 11.43% |
| 2014 Q1 | 6.07 Billion JPY | 1.45% |
| 2014 FY | 25.87 Billion JPY | 14.89% |
| 2014 Q4 | 7.2 Billion JPY | 11.61% |
| 2014 Q3 | 6.45 Billion JPY | 5.3% |
| 2014 Q2 | 6.13 Billion JPY | 0.9% |
| 2013 Q4 | 5.99 Billion JPY | 7.54% |
| 2013 FY | 22.52 Billion JPY | 12.51% |
| 2013 Q1 | 5.07 Billion JPY | -2.35% |
| 2013 Q2 | 5.88 Billion JPY | 15.85% |
| 2013 Q3 | 5.57 Billion JPY | -5.3% |
| 2012 Q1 | 4.73 Billion JPY | -3.41% |
| 2012 Q2 | 4.89 Billion JPY | 3.42% |
| 2012 FY | 20.01 Billion JPY | 13.58% |
| 2012 Q3 | 5.19 Billion JPY | 6.09% |
| 2012 Q4 | 5.2 Billion JPY | 0.15% |
| 2011 Q2 | 3.9 Billion JPY | -4.55% |
| 2011 Q1 | 4.08 Billion JPY | -4.55% |
| 2011 Q3 | 4.73 Billion JPY | 21.35% |
| 2011 Q4 | 4.89 Billion JPY | 3.46% |
| 2011 FY | 17.62 Billion JPY | 16.39% |
| 2010 Q4 | 4.28 Billion JPY | 14.24% |
| 2010 Q2 | 3.49 Billion JPY | -4.87% |
| 2010 Q1 | 3.67 Billion JPY | 9.4% |
| 2010 FY | 15.14 Billion JPY | 21.09% |
| 2010 Q3 | 3.74 Billion JPY | 7.24% |
| 2009 Q3 | 3.13 Billion JPY | -3.51% |
| 2009 FY | 12.5 Billion JPY | 11.52% |
| 2009 Q1 | 2.78 Billion JPY | -3.37% |
| 2009 Q4 | 3.35 Billion JPY | 7.14% |
| 2009 Q2 | 3.24 Billion JPY | 16.86% |
| 2008 Q4 | 2.87 Billion JPY | 4.68% |
| 2008 Q1 | 2.88 Billion JPY | 0.0% |
| 2008 FY | 11.21 Billion JPY | 15.71% |
| 2008 Q3 | 2.74 Billion JPY | 0.41% |
| 2008 Q2 | 2.73 Billion JPY | -5.19% |
| 2007 FY | 9.69 Billion JPY | 5.0% |
| 2006 FY | 9.22 Billion JPY | 7.82% |
| 2005 FY | 8.56 Billion JPY | 1.87% |
| 2004 FY | 8.4 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 43.63 Billion JPY | -46.053% |
| Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 97.566% |
| Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 88.244% |
| Shionogi & Co., Ltd. | 197.62 Billion JPY | 67.749% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -1605.832% |
| Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | 2.887% |
| Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | -119.582% |
| Eisai Co., Ltd. | 533.01 Billion JPY | 88.042% |
| Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -1106.664% |
| Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | 3.143% |
| Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | -37.757% |
| Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | -451.684% |
| Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -674.247% |
| Tsumura & Co. | 48.8 Billion JPY | -30.607% |
| Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | -91.262% |
| Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | -226.232% |
| Fuji Pharma Co., Ltd. | 12.65 Billion JPY | -403.563% |
| Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | -57.51% |
| KYORIN Holdings, Inc. | 45.39 Billion JPY | -40.403% |
| Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -1433.221% |
| Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -972.094% |
| SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -1120.369% |
| MedRx Co., Ltd | 959 Million JPY | -6546.09% |
| Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -2117.885% |
| Solasia Pharma K.K. | 1.47 Billion JPY | -4218.157% |
| Modalis Therapeutics Corporation | 2.37 Billion JPY | -2588.528% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | -163.753% |
| Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | -79.878% |
| Cyfuse Biomedical K.K. | 735.18 Million JPY | -8569.43% |
| Toho Holdings Co., Ltd. | 99.81 Billion JPY | 36.147% |
| Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -2723.567% |